|
1
|
Leelawat K, Narong S, Wannaprasert J and
Leelawat S: Serum NGAL to clinically distinguish cholangiocarcinoma
from benign biliary tract diseases. Int J Hepatol.
2011:8735482011.
|
|
2
|
Srisomsap C, Sawangareetrakul P,
Subhasitanont P, et al: Proteomic studies of cholangiocarcinoma and
hepatocellular carcinoma cell secretomes. J Biomed Biotechnol.
2010:4371432010.
|
|
3
|
Sripa B and Pairojkul C:
Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol.
24:349–356. 2008.
|
|
4
|
Van Beers BE: Diagnosis of
cholangiocarcinoma. HPB (Oxford). 10:87–93. 2008.
|
|
5
|
Kaewpitoon N, Kaewpitoon SJ and Pengsaa P:
Opisthorchiasis in Thailand: review and current status. World J
Gastroenterol. 14:2297–2302. 2008.
|
|
6
|
Chamberlain RS and Blumgart LH: Hilar
cholangiocarcinoma: a review and commentary. Ann Surg Oncol.
7:55–66. 2000.
|
|
7
|
Nakagohri T, Kinoshita T, Konishi M,
Takahashi S and Gotohda N: Surgical outcome and prognostic factors
in intrahepatic cholangiocarcinoma. World J Surg. 32:2675–2680.
2008.
|
|
8
|
Washburn WK, Lewis WD and Jenkins RL:
Aggressive surgical resection for cholangiocarcinoma. Arch Surg.
130:270–276. 1995.
|
|
9
|
Friedl P, Zänker KS and Bröcker EB: Cell
migration strategies in 3-D extracellular matrix: differences in
morphology, cell matrix interactions, and integrin function.
Microsc Res Tech. 43:369–378. 1998.
|
|
10
|
Lomberk G: The extracellular matrix and
cell migration. Pancreatology. 10:4–5. 2010.
|
|
11
|
Painter KJ, Armstrong NJ and Sherratt JA:
The impact of adhesion on cellular invasion processes in cancer and
development. J Theor Biol. 264:1057–1067. 2010.
|
|
12
|
Alvaro D and Mancino MG: New insights on
the molecular and cell biology of human cholangiopathies. Mol
Aspects Med. 29:50–57. 2008.
|
|
13
|
Prakobwong S, Pinlaor S, Yongvanit P,
Sithithaworn P, Pairojkul C and Hiraku Y: Time profiles of the
expression of metalloproteinases, tissue inhibitors of
metalloproteases, cytokines and collagens in hamsters infected with
Opisthorchis viverrini with special reference to peribiliary
fibrosis and liver injury. Int J Parasitol. 39:825–835. 2009.
|
|
14
|
Sripa B, Mairiang E, Thinkhamrop B, et al:
Advanced periductal fibrosis from infection with the carcinogenic
human liver fluke Opisthorchis viverrini correlates with
elevated levels of interleukin-6. Hepatology. 50:1273–1281.
2009.
|
|
15
|
Rattanasinganchan P, Leelawat K,
Treepongkaruna SA, et al: Establishment and characterization of a
cholangiocarcinoma cell line (RMCCA-1) from a Thai patient. World J
Gastroenterol. 12:6500–6506. 2006.
|
|
16
|
Leelawat K, Leelawat S, Narong S and
Hongeng S: Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4
induced cholangiocarcinoma cell invasion. World J Gastroenterol.
13:1561–1568. 2007.
|
|
17
|
Delanote V, Vandekerckhove J and Gettemans
J: Plastins: versatile modulators of actin organization in
(patho)physiological cellular processes. Acta Pharmacol Sin.
26:769–779. 2005.
|
|
18
|
Samstag Y and Klemke M: Ectopic expression
of L-plastin in human tumor cells: diagnostic and therapeutic
implications. Adv Enzyme Regul. 47:118–126. 2007.
|
|
19
|
Delanote V, Van Impe K, De Corte V, et al:
Molecular basis for dissimilar nuclear trafficking of the
actin-bundling protein isoforms T- and L-plastin. Traffic.
6:335–345. 2005.
|
|
20
|
Ben-Ari Y, Brody Y, Kinor N, et al: The
life of an mRNA in space and time. J Cell Sci. 123:1761–1774.
2010.
|
|
21
|
Yamaguchi H and Condeelis J: Regulation of
the actin cytoskeleton in cancer cell migration and invasion.
Biochim Biophys Acta. 1773:642–652. 2007.
|
|
22
|
Otsuka M, Kato M, Yoshikawa T, et al:
Differential expression of the L-plastin gene in human colorectal
cancer progression and metastasis. Biochem Biophys Res Commun.
289:876–881. 2001.
|
